66 related articles for article (PubMed ID: 25925356)
1. Distinguishing thymic cysts from low-risk thymomas via [
Choi S; Kim YI; Han S; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
EJNMMI Res; 2024 May; 14(1):45. PubMed ID: 38702532
[TBL] [Abstract][Full Text] [Related]
2. Vision transformer to differentiate between benign and malignant slices in
Nishigaki D; Suzuki Y; Watabe T; Katayama D; Kato H; Wataya T; Kita K; Sato J; Tomiyama N; Kido S
Sci Rep; 2024 Apr; 14(1):8334. PubMed ID: 38594295
[TBL] [Abstract][Full Text] [Related]
3. MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis.
Dinnes J; Bancos I; Ferrante di Ruffano L; Chortis V; Davenport C; Bayliss S; Sahdev A; Guest P; Fassnacht M; Deeks JJ; Arlt W
Eur J Endocrinol; 2016 Aug; 175(2):R51-64. PubMed ID: 27257145
[TBL] [Abstract][Full Text] [Related]
4. The Monocle Sign on 18F-FDG PET Indicates Contralateral Peripheral Facial Nerve Palsy.
Dana F; Maurer A; Muehlematter UJ; Husmann L; Schaab J; Mader CE; Beintner-Skawran S; Messerli M; Sah BR; Dana M; Dana M; Duhnsen SH; Mueller SA; Stadler T; Morand GB; Meerwein C; Orita E; Kaufmann PA; Huellner MW
Clin Nucl Med; 2024 Apr; ():. PubMed ID: 38651767
[TBL] [Abstract][Full Text] [Related]
5. An exceptional group of non-small cell lung cancer difficult to diagnose: Evaluation of lipid-poor adrenal lesions.
Simsek FS; Arslan M; Dag Y
Bosn J Basic Med Sci; 2019 May; 19(2):195-200. PubMed ID: 30997878
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of
Kim SJ; Lee SW; Pak K; Kim IJ; Kim K
Br J Radiol; 2018 Jun; 91(1086):20170520. PubMed ID: 29327944
[TBL] [Abstract][Full Text] [Related]
7. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
8. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT and FLT-PET/CT for differentiating between lipid-poor benign and malignant adrenal tumours.
Nakajo M; Jinguji M; Fukukura Y; Kajiya Y; Tani A; Nakajo M; Nakabeppu Y; Arimura H; Nishio Y; Nakamura F; Yoshiura T
Eur Radiol; 2015 Dec; 25(12):3696-705. PubMed ID: 25925356
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performances of FDG-PET/CT and diffusion-weighted imaging indices for differentiating benign pheochromocytoma from other benign adrenal tumors.
Nakajo M; Nakajo M; Fukukura Y; Jinguji M; Shindo T; Nakabeppu Y; Kamimura K; Yoneyama T; Takumi K; Yoshiura T
Abdom Imaging; 2015 Aug; 40(6):1655-65. PubMed ID: 25382022
[TBL] [Abstract][Full Text] [Related]
11. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [
